Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Allergy Therapeutics"
Count: 37
Selected: 0
NCT IDTitle
NCT04687059An Exploratory Study of PQ Grass 27600 SU
NCT05186025Tyrosine Allergoid Paediatric and Adult Study
NCT00109759Evaluation of Safety and Tolerability of Tyrosine Adsorbed Ragweed Pollen Allergoid With MPL (Monophosphoryl Lipid A)
NCT00133146Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Grass Pollen Allergy Vaccine
NCT00258635Investigation of Safety+Efficacy of Different Doses of RagweedMATAMPL;Assessment of Residual Allergenicity Using Skin Prick Test
NCT00133159Different Doses of Tyrosine Adsorbed Grass Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Grass Pollen
NCT00118612Different Doses of Tyrosine Adsorbed Tree Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Tree Pollen
NCT04389034Influence of Specific Immunotherapy With Pollinex Quattro (Tree-/Grass Pollen) on Allergen-specific Immunoglobulin E (IgE) Levels
NCT02582073Dose Selection Study of Efficacy and Safety of Different Doses of Grass MATA MPL and Grass MATA Using mEECs™
NCT00387478Investigation of Efficacy and Safety of Tree MATAMPL,Tree MATA, and Placebo in Patients With Birch-Induced Seasonal Allergic Rhinitis
NCT03931993A Study of Tolerability and Safety of a New Cumulative Dose of Grass MATA MPL
NCT02557633A Study of Tolerability and Safety of Two New Doses of Grass MATA MPL
NCT00423787Efficacy and Safety/Tolerability of Ragweed MATA MPL
NCT00414141Efficacy and Safety/Tolerability of Grass MATA MPL
NCT00325338Follow-up Investigation of Efficacy of Ragweed MATAMPL,and Placebo in Patients With Ragweed-induced Seasonal Allergic Rhinitis
NCT00241410Safety, Immunological Effect and Efficacy of the Combined Application of MPL and Grass Pollen Allergen
NCT00118625Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Tree Pollen Allergy Vaccine
NCT00116285Assessment of Residual Allergenicity of Ragweed Pollen Allergoid With Monophosphoryl Lipid A (MPL) Using Skin Prick Testing
NCT00113750Induction of Immunogenicity With Different Doses of TreeMATA in Subjects Allergic to Tree Pollen
NCT00110786Investigation of Efficacy and Safety of Ragweed MATAMPL, Pollinex-R and Placebo in Patients With Ragweed Allergy
NCT00107705Assessment of Residual Allergenicity of Tree (Birch, Hazel, and Alder) Pollen Allergoid Using Skin Prick Testing
NCT00104377Induction of Immunogenicity With Different Doses of Grass MATA in Subjects Allergic to Grass and Rye Pollen
NCT00104390Assessment of Residual Allergenicity of Grass/Rye Pollen Allergoid Using Skin Prick Testing
NCT00417573Efficacy of IgIv in Patients With IgG Subclass Deficiency and Recurrent Infections
NCT00850668Peanut Allergy Vaccine Study in Healthy and Peanut-allergic Adults
NCT02210325Efficacy and Safety Study of Oral Solithromycin Compared to Intramuscular Ceftriaxone Plus Oral Azithromycin in the Treatment of Patients With Gonorrhea
NCT01292070Safety Evaluation of an Experimental Treatment, Intradermal Human Fcγ1-Fel d1 Fusion Protein (GFD), for Cat Allergy
NCT01220531Thymus Transplantation Safety-Efficacy
NCT00579709Thymus Transplantation With Immunosuppression
NCT00849888Serum-Free Thymus Transplantation in DiGeorge Anomaly
NCT00579527Phase I/II Thymus Transplantation With Immunosuppression #950
NCT00576836Thymus Transplantation Dose in DiGeorge #932
NCT00576407Thymus Transplantation in DiGeorge Syndrome #668
NCT01346150Patients Treated for SCID (1968-Present)
NCT02064933Patients Treated for Wiskott-Aldrich Syndrome (WAS) Since 1990
NCT02082353Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995
NCT02042248A Phase I Study to Evaluate the Immunologic Response and Virologic Impact of AGS-004